- Home
- BDX
as 07-26-2024 4:00pm EST
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Upcoming Earnings Alert:
Get ready for potential market movements as Becton Dickinson and Company BDX prepares to release earnings report on 01 Aug 2024.
| Founded: | 1897 | Country: | United States |
| Employees: | N/A | City: | FRANKLIN LAKES |
| Market Cap: | 67.0B | IPO Year: | 1962 |
| Target Price: | $283.13 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.51 | EPS Growth: | -15.54 |
| 52 Week Low/High: | $218.75 - $285.49 | Next Earning Date: | 08-01-2024 |
| Revenue: | $19,716,000,000 | Revenue Growth: | 4.82% |
| Revenue Growth (this year): | 5.47% | Revenue Growth (next year): | 5.79% |
Stock Insider Trading Activity of Becton Dickinson and Company (BDX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Spoerel Thomas J | BDX | SVP,Controller&Chief Acct Off | Jun 10 '24 | Sell | $239.31 | 300 | $71,793.00 | 1,976 | SEC Form 4 |
| Goette Roland | BDX | EVP and President EMEA | May 15 '24 | Sell | $235.29 | 800 | $188,232.00 | 13,808 | SEC Form 4 |
| Goette Roland | BDX | EVP and President EMEA | May 15 '24 | Sell | $236.99 | 1,400 | $331,786.00 | 12,408 | SEC Form 4 |
| Goette Roland | BDX | EVP and President EMEA | May 15 '24 | Sell | $237.46 | 1,100 | $261,206.00 | 11,308 | SEC Form 4 |
| Goette Roland | BDX | EVP and President EMEA | May 13 '24 | Sell | $236.28 | 1,700 | $401,676.00 | 16,208 | SEC Form 4 |
| Goette Roland | BDX | EVP and President EMEA | May 13 '24 | Sell | $237.14 | 1,572 | $372,784.08 | 14,636 | SEC Form 4 |
| Goette Roland | BDX | EVP and President EMEA | May 13 '24 | Sell | $237.90 | 28 | $6,661.20 | 14,608 | SEC Form 4 |
| Garrison Michael David | BDX | EVP & President Medical | Apr 30 '24 | Sell | $232.81 | 1,715 | $399,269.15 | 5,381 | SEC Form 4 |
| Spoerel Thomas J | BDX | SVP,Controller&Chief Acct Off | Mar 15 '24 | Sell | $238.29 | 282 | $67,197.78 | 2,276 | SEC Form 4 |
Latest Becton Dickinson and Company News
BDX Breaking Stock News: Dive into BDX Ticker-Specific Updates for Smart Investing
MT Newswires
9 hours ago
Stifel Adjusts Price Target on Becton, Dickinson to $280 From $270
MT Newswires
a day ago
Becton, Dickinson Partners With Quest Diagnostics on Flow Cytometry-Based Companion Diagnostics
PR Newswire
2 days ago
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
Zacks
3 days ago
Reasons to Add The Cooper Companies (COO) to Your Portfolio Now
PR Newswire
3 days ago
BD Board Declares Dividend
Zacks
3 days ago
What Makes Becton Dickinson (BDX) a New Buy Stock
Zacks
3 days ago
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
Insider Monkey
7 days ago
Here’s Why Madison Investors Fund Sold Becton, Dickinson and Company (BDX)
Compare BDX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BDX Becton Dickinson and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.